Wilzar Fachri
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Interests
Wilzar Fachri has a total of 3 co-authors. Here are the top co-authors by number of shared publications:
- Baitha Palanggatan Maggadani
Pharmaceutical-Medicinal Chemistry and Bioanalysis Laboratory Depok West Java 16424 University of Indonesia Faculty of Pharmacy
1 shared publication - Pedro Anugerah Aswan
Laboratory of Pharmaceutics and Pharmaceutical Technology, Faculty of Pharmacy, Universitas Indonesia, Kampus UI, Depok 16424, Indonesia
1 shared publication - Raditya Iswandana
Laboratory of Pharmaceutics and Pharmaceutical Technology, Faculty of Pharmacy, Universitas Indonesia, Depok 16424, Indonesia
1 shared publication
Latest Publications
- Open Access
- 30 March 2026
- Published by Universitas Gadjah Mada in Indonesian Journal of Chemistry
- Vol. 26 (2) , 572-585
Simultaneous HPLC Analysis of Asiaticoside and α-Mangostin in Nanoethosomal Carriers
The development of robust analytical methods is essential for quality control of nanoethosomal formulations containing asiaticoside and α-mangostin, bioactive compounds with anti-inflammatory and antioxidant properties. Simultaneous quantification within nanocarriers is challenging and requires validated techniques. This study established a precise HPLC method, in accordance with ICH Q2(R2) guidelines, for the concurrent determination of both compounds. The technique demonstrated excellent linearity (R2 > 0.999), precision (%RSD < 2%), and accuracy (95–105% recovery). The nanoethosomal system also achieved high encapsulation efficiencies of 94.76% for asiaticoside and 99.27% for α-mangostin. This validated method provides a reliable tool for standardizing these complex nano-formulations, supporting their further development and clinical translation.
- 30 March 2026
- Published by Universitas Gadjah Mada in Indonesian Journal of Chemistry
- Vol. 26 (2) , 572-585
Open AccessSimultaneous HPLC Analysis of Asiaticoside and α-Mangostin in Nanoethosomal Carriers
The development of robust analytical methods is essential for quality control of nanoethosomal formulations containing asiaticoside and α-mangostin, bioactive compounds with anti-inflammatory and antioxidant properties. Simultaneous quantification within nanocarriers is challenging and requires validated techniques. This study established a precise HPLC method, in accordance with ICH Q2(R2) guidelines, for the concurrent determination of both compounds. The technique demonstrated excellent linearity (R2 > 0.999), precision (%RSD < 2%), and accuracy (95–105% recovery). The nanoethosomal system also achieved high encapsulation efficiencies of 94.76% for asiaticoside and 99.27% for α-mangostin. This validated method provides a reliable tool for standardizing these complex nano-formulations, supporting their further development and clinical translation.